1–4 of 4 results for photobiomodulation
Multiwavelength Photobiomodulation Significantly Reduces Risk for Vision Loss and Onset of Geographic Atrophy in Dry Age-Related Macular Degeneration
Eleonora Lad, MD, PhD
Updates from the Field
2024
LIGHTSITE III Analysis: 24-Month Evaluation of Multiwavelength Photobiomodulation
Nathan C. Steinle, MD
Efficacy and Safety of Multiwavelength Photobiomodulation in Dry Age-Related Macular Degeneration Using the LumiThera Valeda System (LIGHTSITE III Interim Analysis)
Richard B. Rosen, MD, DSc(Hon), FACS, FASRS, FARVO
2022
Photobiomodulation for DME With Good VA: DRCRnet Protocol AE
Judy E. Kim, MD, FASRS
2021